CSIMarket
 


Kala Pharmaceuticals, Inc.  (KALA)
Other Ticker:  
 

Kala Pharmaceuticals's Working Capital Ratio

KALA's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




KALA Working Capital Ratio (Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
Y / Y Current Liabilities Change 177.87 % 14.45 % - - -
Y / Y Current Assets Change 48.35 % 53.65 % - - -
Working Capital Ratio MRQ 11.59 10.7 6.39 10 21.71
Overall Ranking # # # # #
Seq. Current Liabilities Change -21.54 % 31.49 % 36.86 % 96.81 % -67.69 %
Seq. Current Assets Change -15.01 % 120.03 % -12.49 % -9.35 % -11.98 %



Working Capital Ratio first quarter 2019 Comment
Current Liabilities decreased faster than Kala Pharmaceuticals's Current Assets, this led to improvement in Kala Pharmaceuticals's Working Capital Ratio to 11.59, Working Capital Ratio remained below Kala Pharmaceuticals, Inc. average.

Within Major Pharmaceutical Preparations industry 56 other companies have achieved higher Working Capital Ratio than Kala Pharmaceuticals in first quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is KALA most successful ?
Working Capital Ratio KALA on the trailing twelve month basis
Working Capital Ratio first quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 57
Healthcare Sector # 109
Overall Market # 343


Working Capital Ratio Statistics
High Average Low
21.71 11.39 6.39
(Mar 31 2018)   (Sep 30 2018)




Financial Statements
Kala Pharmaceuticals's Current Liabilities $ 13 Millions Visit KALA's Balance sheet
Kala Pharmaceuticals's Current Assets $ 150 Millions Visit KALA's Balance sheet
Source of KALA's Sales Visit KALA's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingMar 31 2019, within Major Pharmaceutical Preparations Industry Working Capital RatioMar 31 2019 MRQ Current AssetsMar 31 2019 MRQ Current Liabilities
Restorbio, Inc.  31.39 $ 144.678  Millions$ 4.609  Millions
Genprex, Inc.  30.49 $ 7.046  Millions$ 0.231  Millions
Prothena Corp Plc  27.85 $ 415.193  Millions$ 14.906  Millions
Verrica Pharmaceuticals Inc.  27.65 $ 84.677  Millions$ 3.062  Millions
Inspire Medical Systems, Inc.  24.09 $ 188.543  Millions$ 7.826  Millions
Glycomimetics Inc  23.89 $ 198.442  Millions$ 8.307  Millions
Neurotrope, Inc.  23.11 $ 24.459  Millions$ 1.058  Millions
Aquinox Pharmaceuticals, Inc  22.04 $ 74.831  Millions$ 3.396  Millions
Phasebio Pharmaceuticals Inc  21.80 $ 54.075  Millions$ 2.481  Millions
Marker Therapeutics, Inc.  21.09 $ 58.035  Millions$ 2.752  Millions
Enanta Pharmaceuticals Inc  20.68 $ 423.840  Millions$ 20.491  Millions
Allakos Inc.  20.49 $ 168.699  Millions$ 8.232  Millions
Concert Pharmaceuticals, Inc.  20.44 $ 161.784  Millions$ 7.915  Millions
Sage Therapeutics, Inc.  20.06 $ 1,371.532  Millions$ 68.376  Millions
Principia Biopharma Inc.  19.71 $ 166.913  Millions$ 8.469  Millions
Achillion Pharmaceuticals Inc  19.66 $ 259.090  Millions$ 13.179  Millions
Cymabay Therapeutics, Inc.  18.66 $ 270.064  Millions$ 14.473  Millions
Aratana Therapeutics, Inc.  18.16 $ 53.922  Millions$ 2.969  Millions
Crinetics Pharmaceuticals, Inc.  18.04 $ 159.115  Millions$ 8.818  Millions
Xenon Pharmaceuticals Inc.  17.57 $ 112.047  Millions$ 6.376  Millions
Allogene Therapeutics, Inc.  17.48 $ 476.627  Millions$ 27.265  Millions
Seres Therapeutics, Inc.  17.29 $ 67.755  Millions$ 3.918  Millions
Magenta Therapeutics, Inc.  17.08 $ 135.272  Millions$ 7.920  Millions
Galectin Therapeutics Inc  16.70 $ 7.483  Millions$ 0.448  Millions
Prophase Labs, Inc.  16.24 $ 14.126  Millions$ 0.870  Millions
Evolus, Inc.  16.18 $ 139.084  Millions$ 8.598  Millions
Apellis Pharmaceuticals, Inc.  16.12 $ 310.528  Millions$ 19.259  Millions
Dermira, Inc.  15.87 $ 443.008  Millions$ 27.907  Millions
Albireo Pharma, Inc.  15.53 $ 154.336  Millions$ 9.941  Millions
Revance Therapeutics, Inc.  15.39 $ 277.116  Millions$ 18.007  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DDLX's Profile

Stock Price

DDLX's Financials

Business Description

Fundamentals

Charts & Quotes

DDLX's News

Suppliers

DDLX's Competitors

Customers & Markets

Economic Indicators

DDLX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071